The mechanism sits upstream of anything you can feel: blocking NNMT stops nicotinamide being methylated into 1-MNA, which raises intracellular NAD+ and SAM and suppresses fat-cell lipogenesis
Most consumer products containing BPC-157 are labeled as research chemicals and marked as "not for human consumption." These formulations are unregulated and do not comply with manufacturing quality control requirements enforced for dietary supplements
The 2.5 mg dose is better called the low-dose starter, because it is the labeled start and now has short direct non-diabetic data behind it. Microdosing has been used for tolerability testing, metabolic-marker support, step-down protocols, and maintenance, not for proven long-term obesity outcomes
It does not inhibit myostatin, the natural brake on muscle size
This breadth of application speaks to the fundamental nature of the healing processes that BPC-157 supports
Overdoing it can occasionally lead to side effects like nerve irritation (with too much B6), skin flushing (from high-dose B3), or digestive upset